Connection

Nivedita Gupta to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Nivedita Gupta has written about Antibodies, Viral.
Nivedita Gupta
Connection Strength
0.081
Antibodies, Viral
  1. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May; 151(5):444-449.
    View in: PubMed
    Score: 0.021
  2. Comparison of two commercial ELISA kits for detection of rubella specific IgM in suspected congenital rubella syndrome cases and rubella IgG antibodies in a serosurvey of pregnant women. Diagn Microbiol Infect Dis. 2019 Jul; 94(3):243-247.
    View in: PubMed
    Score: 0.019
  3. Sero-prevalence of rubella among pregnant women in India, 2017. Vaccine. 2018 12 18; 36(52):7909-7912.
    View in: PubMed
    Score: 0.019
  4. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 01; 28(4).
    View in: PubMed
    Score: 0.006
  5. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun. 2021 03 02; 12(1):1386.
    View in: PubMed
    Score: 0.006
  6. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
    View in: PubMed
    Score: 0.005
  7. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):93-114.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.